How to discriminate between potentially novel and considered biomarkers within molecular signature?
10.1109/CIBCB.2013.6595405
Saved in:
Main Authors: | Ow, G.S., Jenjaroenpun, P., Thiery, J.P., Kuznetsov, V.A. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Conference or Workshop Item |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/110801 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
INTEGRATED GENOMIC MARKERS FOR CHEMOTHERAPEUTICS
by: WU SONG
Published: (2012) -
Molecular biomarkers in schizophrenia - implications for clinical practice
by: Lee, J., et al.
Published: (2016) -
Local atherosclerotic plaques are a source of prognostic biomarkers for adverse cardiovascular events
by: De Kleijn, D.P.V., et al.
Published: (2014) -
ASSESSING POTENTIAL INFLAMMATORY BIOMARKERS AND ANTI-NEUROINFLAMMATORY THERAPIES FOR ALZHEIMER'S DISEASE
by: ZHU YANAN
Published: (2018) -
Utilizing an animal model to identify brain neurodegeneration-related biomarkers in aging
by: Yang, Ming-Hui, et al.
Published: (2022)